Summary Rising Pharmaceuticals Inc (Rising Pharma), a subsidiary of Aceto Corp is a manufacturer and distributor of prescription and over the counter pharmaceutical products. The company offers products such as amiloride hydrochloride, benztropine, anastrozole, carisoprodol, codeine phosphate, cetirizine hydrochloride, cevimeline hydrochloride, ciprofloxacin ophthalmic solution, floranex, ciprofloxacin and clindamycin palmitate hydrochloride oral solution, among others. Its products are used in the therapeutic areas of cardiovascular, dermatology, dentistry, malaria, muskoskeletal, women’s health, respiratory and gastrointestinal. The company markets its products through a network of distributors. Rising Pharma is headquartered in Allendale, New Jersey, the US. Rising Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the... Research Beam Model: Research Beam Product ID: 1951416 250 USD New
Rising Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Rising Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Healthcare
  • Published On : August   2017
  • Pages : 22
  • Publisher : GlobalData
 
 
 
Summary

Rising Pharmaceuticals Inc (Rising Pharma), a subsidiary of Aceto Corp is a manufacturer and distributor of prescription and over the counter pharmaceutical products. The company offers products such as amiloride hydrochloride, benztropine, anastrozole, carisoprodol, codeine phosphate, cetirizine hydrochloride, cevimeline hydrochloride, ciprofloxacin ophthalmic solution, floranex, ciprofloxacin and clindamycin palmitate hydrochloride oral solution, among others. Its products are used in the therapeutic areas of cardiovascular, dermatology, dentistry, malaria, muskoskeletal, women’s health, respiratory and gastrointestinal. The company markets its products through a network of distributors. Rising Pharma is headquartered in Allendale, New Jersey, the US.

Rising Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Rising Pharma Acquires Generic Products and Related Assets of Citron Pharma and Lucid Pharma for USD429 Million 10
Rising Pharma to Acquire Three ANDAs from Endo International 12
Rising Pharma Acquires Three Opthalmic ANDA's from Nexus Pharma 13
Rising Pharma Acquires Doxercalciferol, Paricalcitol and Dutasteride from Par Pharma 14
Partnerships 15
Panacea Biotec Enters into Agreement with Rising Pharma 15
Rising Pharma Enters Into Co-Marketing Agreement With Covis Pharma For Parnate 16
Asset Transactions 17
Aceto Acquires Certain Assets From Rising Pharma 17
Rising Pharmaceuticals Inc - Key Competitors 19
Rising Pharmaceuticals Inc - Key Employees 20
Rising Pharmaceuticals Inc - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rising Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Rising Pharma Acquires Generic Products and Related Assets of Citron Pharma and Lucid Pharma for USD429 Million 10
Rising Pharma to Acquire Three ANDAs from Endo International 12
Rising Pharma Acquires Three Opthalmic ANDA's from Nexus Pharma 13
Rising Pharma Acquires Doxercalciferol, Paricalcitol and Dutasteride from Par Pharma 14
Panacea Biotec Enters into Agreement with Rising Pharma 15
Rising Pharma Enters Into Co-Marketing Agreement With Covis Pharma For Parnate 16
Aceto Acquires Certain Assets From Rising Pharma 17
Rising Pharmaceuticals Inc, Key Competitors 19
Rising Pharmaceuticals Inc, Key Employees 20
List of Figures
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rising Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter